SCHEMBL131236

SCHEMBL131236

CCCCOOC(C)(C)OC(=O)OC(C)(C)OOCCCC

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
ATM Q13315 1/20 0.36
TSHR P16473 5/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 1/20 0.34
HCAR2 Q8TDS4 1/20 0.32
CES2 O00748 3/20 0.32
NAAA Q02083 1/20 0.31
DGKA P23743 1/20 0.31
CYP3A4 P08684 2/20 0.31
HSD17B10 Q99714 1/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.31
ACHE P22303 1/20 0.31
CES1 P23141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8593906 0.94 NAAA (0.38) ALDH1A1TSHRHCAR2CES2NAAA
SCHEMBL1581661 0.92 NAAA (0.41) ALDH1A1TSHRHCAR2CES2NAAA
SCHEMBL28052200 0.91 ALDH1A1 (0.44) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28142643 0.91 CA1 (0.38) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28268150 0.89 ALDH1A1 (0.38) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28132615 0.89 ALDH1A1 (0.40) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28135302 0.88 ALDH1A1 (0.33) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28141874 0.88 ALDH1A1 (0.37) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL28269818 0.88 NAAA (0.42) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL131237 0.86 ALDH1A1 (0.38) ALDH1A1ATMTSHRTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890893-A Fluoroelastomer composition 索尔维特殊聚合物意大利有限公司 2019-06-14 CN claimed
CN-109863151-A Fused tricyclic pyridazinone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2019-06-07 CN claimed
CN-109715718-A Fluoroelastomer composition 索尔维特殊聚合物意大利有限公司 2019-05-03 CN claimed
CN-106632483-A Tenofovir disoproxil preparation method 青岛辰达生物科技有限公司 2017-05-10 CN claimed
CN-106008603-A Preparation methods of tenofovir disoproxil and fumarate thereof 东北制药集团股份有限公司 2016-10-12 CN claimed
CN-104066775-B Fibre-reinforced resin mold plastics and manufacture the method for fibre-reinforced molded resin by it OCV INTELLECTUAL CAPITAL, LLC (US) 2016-06-01 CN claimed
CN-102201563-B Injection method of lithium ion battery electrolyte and the battery prepared SHENZHEN BAK BATTERY CO., LTD. (CN) 2016-02-10 CN claimed
CN-105283179-A Novel analogues of epicatechin and related polyphenols SPHAERA PHARMA PRIVATE LTD 2016-01-27 CN claimed
US-7740826-B2 Method for functionalizing carbon nanotubes utilizing peroxides WILLIAM MARSH RICE UNIVERSITY (US) 2010-06-22 US claimed
US-20090306427-A1 Chemical Functionalization of Carbon Nanotubes NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2009-12-10 US claimed
EP-1989143-A1 CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES National Research Council of Canada (CA) 2008-11-12 EP claimed
WO-2007098578-A1 CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2007-09-07 WO claimed
US-20070098620-A1 Method for functionalizing carbon nanotubes utilizing peroxides WILLIAM MARSH RICE UNIVERSITY (US) 2007-05-03 US claimed
WO-2006110305-A1 PHOTOCHROMIC OPHTHALMIC DEVICES MADE WITH DUAL INITIATOR SYSTEM JOHNSON & JOHNSON VISION CARE, INC. (US) 2006-10-19 WO claimed
US-20040223900-A1 Method for functionalizing carbon nanotubes utilizing peroxides WILLIAM MARSH RICE UNIVERSITY (US) 2004-11-11 US claimed
US-6432543-B1 None US disclosed
US-20260117048-A1 MODIFIER FOR POLYAMIDE RESINS AND POLYAMIDE RESIN COMPOSITION KANEKA CORPORATION (JP) 2026-04-30 US disclosed
US-3988507-A Anaerobically hardening adhesives and sealants containing a hydrazone accelerator HENKEL & CIE G.M.B.H. (DT) 1976-10-26 US disclosed
US-3987019-A ACRYLIC ESTER, PEROXIDE POLYMERIZATION CATALYST HENKEL & CIE G.M.B.H. (DT) 1976-10-19 US disclosed
US-3984385-A ORGANIC SULFONIC ACID HYDRAZIDE HENKEL & CIE G.M.B.H. (DT) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117048-A1 MODIFIER FOR POLYAMIDE RESINS AND POLYAMIDE RESIN COMPOSITION MEP1A, SMCHD1, SMC1A ALDH1A1 1362/4885ATM 1974/4885TSHR 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.